These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 36405723)

  • 1. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.
    Schubert D; Bode C; Kenefeck R; Hou TZ; Wing JB; Kennedy A; Bulashevska A; Petersen BS; Schäffer AA; Grüning BA; Unger S; Frede N; Baumann U; Witte T; Schmidt RE; Dueckers G; Niehues T; Seneviratne S; Kanariou M; Speckmann C; Ehl S; Rensing-Ehl A; Warnatz K; Rakhmanov M; Thimme R; Hasselblatt P; Emmerich F; Cathomen T; Backofen R; Fisch P; Seidl M; May A; Schmitt-Graeff A; Ikemizu S; Salzer U; Franke A; Sakaguchi S; Walker LSK; Sansom DM; Grimbacher B
    Nat Med; 2014 Dec; 20(12):1410-1416. PubMed ID: 25329329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency.
    Turnbull C; Bones J; Stanley M; Medhavy A; Wang H; Lorenzo AMD; Cappello J; Shanmuganandam S; Pandey A; Seneviratne S; Brown GJ; Meng X; Fulcher D; Burgio G; Man SM; de Lucas Collantes C; Gasior M; López Granados E; Martin P; Jiang SH; Cook MC; Ellyard JI; Athanasopoulos V; Corry B; Canete PF; Vinuesa CG
    Sci Adv; 2023 Dec; 9(49):eadi9566. PubMed ID: 38055819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity.
    Maccari ME; Wolkewitz M; Schwab C; Lorenzini T; Leiding JW; Aladjdi N; Abolhassani H; Abou-Chahla W; Aiuti A; Azarnoush S; Baris S; Barlogis V; Barzaghi F; Baumann U; Bloomfield M; Bohynikova N; Bodet D; Boutboul D; Bucciol G; Buckland MS; Burns SO; Cancrini C; Cathébras P; Cavazzana M; Cheminant M; Chinello M; Ciznar P; Coulter TI; D'Aveni M; Ekwall O; Eric Z; Eren E; Fasth A; Frange P; Fournier B; Garcia-Prat M; Gardembas M; Geier C; Ghosh S; Goda V; Hammarström L; Hauck F; Heeg M; Heropolitanska-Pliszka E; Hilfanova A; Jolles S; Karakoc-Aydiner E; Kindle GR; Kiykim A; Klemann C; Koletsi P; Koltan S; Kondratenko I; Körholz J; Krüger R; Jeziorski E; Levy R; Le Guenno G; Lefevre G; Lougaris V; Marzollo A; Mahlaoui N; Malphettes M; Meinhardt A; Merlin E; Meyts I; Milota T; Moreira F; Moshous D; Mukhina A; Neth O; Neubert J; Neven B; Nieters A; Nove-Josserand R; Oksenhendler E; Ozen A; Olbrich P; Perlat A; Pac M; Schmid JP; Pacillo L; Parra-Martinez A; Paschenko O; Pellier I; Sefer AP; Plebani A; Plantaz D; Prader S; Raffray L; Ritterbusch H; Riviere JG; Rivalta B; Rusch S; Sakovich I; Savic S; Scheible R; Schleinitz N; Schuetz C; Schulz A; Sediva A; Semeraro M; Sharapova SO; Shcherbina A; Slatter MA; Sogkas G; Soler-Palacin P; Speckmann C; Stephan JL; Suarez F; Tommasini A; Trück J; Uhlmann A; van Aerde KJ; van Montfrans J; von Bernuth H; Warnatz K; Williams T; Worth AJJ; Ip W; Picard C; Catherinot E; Nademi Z; Grimbacher B; Forbes Satter LR; Kracker S; Chandra A; Condliffe AM; Ehl S;
    J Allergy Clin Immunol; 2023 Oct; 152(4):984-996.e10. PubMed ID: 37390899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry.
    Rojas-Restrepo J; Sindram E; Zenke S; Haberstroh H; Mitsuiki N; Gabrysch A; Huebscher K; Posadas-Cantera S; Krausz M; Kobbe R; Rohr JC; Grimbacher B; Gámez-Díaz L
    J Clin Immunol; 2023 Nov; 43(8):2076-2089. PubMed ID: 37740092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balance and imbalance in the immune system: life on the edge.
    Topalian SL; Sharpe AH
    Immunity; 2014 Nov; 41(5):682-4. PubMed ID: 25517610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrafamilial clinical variability of CTLA-4 insufficiency hindering early diagnosis.
    Karadağ ŞİK; Hancıoğlu G; Akçam B; Altundağ E; Barış S; Yıldıran A
    Klin Padiatr; 2024 Jan; 236(1):39-42. PubMed ID: 37989213
    [No Abstract]   [Full Text] [Related]  

  • 7. Expanding the molecular and phenotypic spectrum of CTLA-4 insufficiency.
    Duke S; Maiarana J; Yousefi P; Burks E; Gerrie S; Setiadi A; ; Hildebrand KJ; James E; Turvey SE; Markle JG; Biggs CM
    Pediatr Allergy Immunol; 2024 Feb; 35(2):e14077. PubMed ID: 38351878
    [No Abstract]   [Full Text] [Related]  

  • 8. Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches.
    Tessarin G; Baronio M; Lougaris V
    Curr Opin Allergy Clin Immunol; 2023 Dec; 23(6):461-466. PubMed ID: 37767915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What did we learn from CTLA-4 insufficiency on the human immune system?
    Mitsuiki N; Schwab C; Grimbacher B
    Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story.
    Quaglia M; Merlotti G; De Andrea M; Borgogna C; Cantaluppi V
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
    Krausz M; Mitsuiki N; Falcone V; Komp J; Posadas-Cantera S; Lorenz HM; Litzman J; Wolff D; Kanariou M; Heinkele A; Speckmann C; Häcker G; Hengel H; Gámez-Díaz L; Grimbacher B
    Front Immunol; 2022; 13():1011646. PubMed ID: 36405723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Risk for Malignancies in 131 Affected
    Egg D; Schwab C; Gabrysch A; Arkwright PD; Cheesman E; Giulino-Roth L; Neth O; Snapper S; Okada S; Moutschen M; Delvenne P; Pecher AC; Wolff D; Kim YJ; Seneviratne S; Kim KM; Kang JM; Ojaimi S; McLean C; Warnatz K; Seidl M; Grimbacher B
    Front Immunol; 2018; 9():2012. PubMed ID: 30250467
    [No Abstract]   [Full Text] [Related]  

  • 13. High frequencies of asymptomatic Epstein-Barr virus viremia in affected and unaffected individuals with CTLA4 mutations.
    Hoshino A; Tanita K; Kanda K; Imadome KI; Shikama Y; Yasumi T; Imai K; Takagi M; Morio T; Kanegane H
    Clin Immunol; 2018 Oct; 195():45-48. PubMed ID: 30048690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.
    Schwab C; Gabrysch A; Olbrich P; Patiño V; Warnatz K; Wolff D; Hoshino A; Kobayashi M; Imai K; Takagi M; Dybedal I; Haddock JA; Sansom DM; Lucena JM; Seidl M; Schmitt-Graeff A; Reiser V; Emmerich F; Frede N; Bulashevska A; Salzer U; Schubert D; Hayakawa S; Okada S; Kanariou M; Kucuk ZY; Chapdelaine H; Petruzelkova L; Sumnik Z; Sediva A; Slatter M; Arkwright PD; Cant A; Lorenz HM; Giese T; Lougaris V; Plebani A; Price C; Sullivan KE; Moutschen M; Litzman J; Freiberger T; van de Veerdonk FL; Recher M; Albert MH; Hauck F; Seneviratne S; Pachlopnik Schmid J; Kolios A; Unglik G; Klemann C; Speckmann C; Ehl S; Leichtner A; Blumberg R; Franke A; Snapper S; Zeissig S; Cunningham-Rundles C; Giulino-Roth L; Elemento O; Dückers G; Niehues T; Fronkova E; Kanderová V; Platt CD; Chou J; Chatila TA; Geha R; McDermott E; Bunn S; Kurzai M; Schulz A; Alsina L; Casals F; Deyà-Martinez A; Hambleton S; Kanegane H; Taskén K; Neth O; Grimbacher B
    J Allergy Clin Immunol; 2018 Dec; 142(6):1932-1946. PubMed ID: 29729943
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.